Literature DB >> 10369293

Establishment and characterization of human laryngeal squamous cell carcinoma cell lines.

J L Ku1, W H Kim, J H Lee, H S Park, K H Kim, M W Sung, J G Park.   

Abstract

OBJECTIVES: Six human laryngeal squamous cell carcinoma cell lines (SNU-46, -585, -899, -1066, -1076, -1214) established from Korean patients are reported. STUDY
DESIGN: In vitro culture of six squamous cell carcinoma cell lines derived from primary tumors of the larynx. Description of the cell line phenotypes and determination of molecular characteristics.
METHODS: Six laryngeal squamous cell carcinoma cell lines were cultured. The cell phenotypes, including the histopathology of the primary tumors and in vitro growth characteristics, were determined. Molecular characterization was also performed, including DNA fingerprinting analysis and abnormalities of p15, p16, p53, and TGF-betaRII genes by polymerase chain reaction-based single strand conformation polymorphism and sequencing analysis.
RESULTS: All cell lines grew as adherent cells; five lines grew as monolayers and one other line grew as stratifying colonies. All lines showed 1) high viability (75%-92%) with various doubling times (36-96 h); 2) absence of Mycoplasma and other bacteria; and 3) genetic heterogeneity by DNA profile analysis. p53 Mutations were found in three lines and p16 mutations were observed in five cell lines. TGF-betaRII mutations were found in two lines: one line had frameshift mutation and another line had a missense mutation at the kinase domain.
CONCLUSIONS: These newly established and characterized laryngeal squamous cell carcinoma cell lines will be useful for investigating the biologic characteristics of laryngeal cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369293     DOI: 10.1097/00005537-199906000-00025

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

2.  Growth Inhibitory Effect of Palatine Tonsil-derived Mesenchymal Stem Cells on Head and Neck Squamous Cell Carcinoma Cells.

Authors:  Yun-Sung Lim; Jin-Choon Lee; Yoon Se Lee; Byung-Joo Lee; Soo-Geun Wang
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-06-12       Impact factor: 3.372

3.  miR-375 and miR-205 Regulate the Invasion and Migration of Laryngeal Squamous Cell Carcinoma Synergistically via AKT-Mediated EMT.

Authors:  Bin Wang; Kexing Lv; Weixiong Chen; Jing Zhao; Jie Luo; Jianhui Wu; Zenghong Li; Hao Qin; Thian-Sze Wong; Weiqiang Yang; Qing-Ling Fu; Wenbin Lei
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

4.  MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.

Authors:  John Zeng-Hong Li; Wei Gao; Wen-Bin Lei; Jing Zhao; Jimmy Yu-Wai Chan; William Ignace Wei; Wei-Kuen Ho; Thian-Sze Wong
Journal:  Oncotarget       Date:  2016-09-06

5.  Cell Model Passports-a hub for clinical, genetic and functional datasets of preclinical cancer models.

Authors:  Dieudonne van der Meer; Syd Barthorpe; Wanjuan Yang; Howard Lightfoot; Caitlin Hall; James Gilbert; Hayley E Francies; Mathew J Garnett
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 19.160

6.  Change of the expression of human telomerase reverse transcriptase mRNA and human telomerase RNA after cisplatin and 5-fluorouracil exposure in head and neck squamous cell carcinoma cell lines.

Authors:  Byung Joo Lee; Bae Hyuk Lee; Soo Geun Wang; Jin Choon Lee; Hwan Jung Roh; Eui Kyung Goh; Cheol Min Kim; Eun Sook Jun
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

7.  Establishment and characterisation of six human biliary tract cancer cell lines.

Authors:  J-L Ku; K-A Yoon; I-J Kim; W-H Kim; J-Y Jang; K-S Suh; S-W Kim; Y-H Park; J-H Hwang; Y-B Yoon; J-G Park
Journal:  Br J Cancer       Date:  2002-07-15       Impact factor: 7.640

8.  Accelerated elimination of human cancer cells by a CD40 agonist antibody combined with a PD-1 antagonist in CD4-depleted mice.

Authors:  Soon-Hyun Ahn; Joo Yeon Choi; Seong Dong Kim; Sung Joon Park; Hyojin Kim
Journal:  Oncol Lett       Date:  2019-10-14       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.